<ul>
<li>西门子公司将以 51 亿美元收购全球软件投资者 Insight Partners 旗下的 Dotmatics</li>
<li>此次收购加速了 Dotmatics 将科学发现与交付相连接的使命，扩大了其全球规模和影响力</li>
<li>解锁了将 Dotmatics 的研发软件与西门子基于人工智能的数字双胞胎技术相结合的新机会</li>
<li>代表了对 Dotmatics 在科学软件领域的增长、创新和领导力的强有力验证</li>
</ul>
<p>, /PRNewswire/ -- Dotmatics®是一家领先的科学软件提供商，提供端到端解决方案以连接生命科学研发中的科学、数据和决策，今天宣布已签署最终协议，将以 51 亿美元被西门子公司收购。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Dotmatics 已签署协议将被西门子收购</p>
<p>&#34;在与 Insight Partners 的激动人心的旅程之后，Dotmatics 实现了显著的增长和投资组合扩展，我们很高兴地宣布与西门子开启新的篇章，&#34; Dotmatics 首席执行官 Thomas Swalla 表示。&#34;将我们的下一代科学智能平台和行业领先的科学应用与西门子的数字双胞胎和人工智能能力结合在一起，我们将推动生命科学研发领域的新一波创新。我们将共同加速客户的创新周期，帮助科学家比以往更快地取得突破性发现，塑造科学创新的未来。&#34;</p>
<p>&#34;通过收购 Dotmatics，我们正在战略性地增强在生命科学领域的地位，并作为西门子 Xcelerator 的一部分创建一个全球领先的基于人工智能的 PLM 软件组合。人工智能已成为各行业的变革性力量，其在生命科学中的应用变得越来越重要，&#34; 西门子公司总裁兼首席执行官 Roland Busch 表示。&#34;Dotmatics 的收购是我们 ONE Tech Company 增长计划的一部分，增强了我们在工业软件领域的领先地位，并帮助我们的客户更快地创新。&#34;</p>
<p>此次收购将增强西门子和 Dotmatics 通过先进软件解决方案赋能科学家的能力，这些解决方案促进下一代协作、上下文化复杂数据，并利用人工智能加速研究。作为西门子的一部分，Dotmatics 将受益于扩展的全球资源、强大的基础设施和更广泛的客户网络，显著推进其革命性科学发现的使命，以创造一个更健康、更清洁和更安全的世界。</p>
<p>生命科学是全球发展最快、创新最丰富的行业之一。西门子广泛的制造专业知识、工业仿真能力和人工智能优势与 Dotmatics 互补的科学应用相结合，将建立一个首创的端到端数字线程，顺畅连接生命科学行业的研究数据与生产。</p>
<p>&#34;当我们在 2017 年首次投资于现在的 Dotmatics 时，我们意识到该平台的巨大潜力以及公司技术对生命科学研发的影响，&#34; Insight Partners 的董事总经理 Jared Rosen 表示。&#34;与 Thomas 和 Dotmatics 领导团队密切合作，积极支持 14 项战略收购，并通过我们的 Onsite 平台提供资源以推动他们的显著增长，是一种特权。Dotmatics 从 Insight Partners 过渡到西门子代表了一个合乎逻辑的下一步，赋能 Dotmatics 进一步推进其加速生命科学创新的使命。这次收购开启了无缝连接科学发现与制造执行的新途径，使科学研发组织能够快速而自信地将突破性成果从分子转化为市场。&#34;</p>
<p><strong>批准与时间</strong> 该交易预计将在获得惯例监管批准和其他成交条件后完成。</p>
<p><strong>顾问</strong> Evercore 担任 Dotmatics 交易的独家财务顾问，Willkie Farr &amp; Gallagher LLP 担任法律顾问。</p>
<p><strong>关于 Dotmatics</strong> Dotmatics 是连接科学、数据和决策的研发科学软件领导者。其企业研发平台和应用程序，包括 GraphPad Prism、SnapGene 和 Geneious，推动效率并加速创新。超过 200 万科学家和 14,000 个客户信任 Dotmatics，帮助他们创造一个更健康、更清洁、更安全的世界。Dotmatics 是一支由 800 多人组成的全球团队，致力于支持其在 180 多个国家的客户。公司总部位于波士顿，在全球设有 14 个办公室和研发团队。了解更多关于 Dotmatics 的信息，请访问 www.dotmatics.com。</p>
<p><strong>关于西门子</strong> 西门子公司（柏林和慕尼黑）是一家领先的技术公司，专注于工业、基础设施、移动和医疗保健。公司的宗旨是创造技术以改变日常生活，为每个人服务。通过将现实世界与数字世界相结合，西门子使客户能够加速其数字化和可持续性转型，使工厂更高效、城市更宜居、交通更可持续。西门子还拥有上市公司西门子医疗的控股权，西门子医疗是一家全球领先的医疗技术提供商，开创了医疗保健领域的突破性进展。为每个人。无处不在。可持续发展。在 2024 财年（截至 2024 年 9 月 30 日），西门子集团的收入为 759 亿欧元，净收入为 90 亿欧元。截至 2024 年 9 月 30 日，公司在持续运营的基础上全球雇佣约 312,000 名员工。有关更多信息，请访问 www.siemens.com。</p>
<p><strong>关于 Insight Partners</strong> Insight Partners 是一家全球软件投资公司，专注于与高增长的科技、软件和互联网初创企业及规模化公司合作，这些公司正在推动其行业的变革。截至 2024 年 9 月 30 日，该公司管理的监管资产超过 900 亿美元。Insight Partners 已在全球投资了 800 多家公司，并且已有超过 55 家投资组合公司成功上市。公司总部位于纽约市，在伦敦、特拉维夫和湾区设有办事处。Insight 的使命是寻找、资助并与具有远见的高管成功合作，为他们提供量身定制的、实用的软件专业知识，伴随他们的成长旅程，从首次投资到上市。有关 Insight 及其所有投资的更多信息，请访问 insightpartners.com 或在 X 上关注我们 @insightpartners。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含前瞻性声明，这些声明不仅仅涉及历史或当前事实，例如关于我们对未来的期望、意图或战略的声明。这些前瞻性声明基于管理层的信念，以及 Dotmatics 所做的假设和当前可获得的信息。由于这些声明是基于对未来经营结果的期望，因此并非事实陈述。实际结果可能与预测结果有重大差异，并且受到已知和未知风险和不确定性的影响。新闻稿仅在声明首次发布的日期有效。Dotmatics 不承担更新任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因。</p>
<p>来源：Dotmatics Inc</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNDAyJk5ld3NJdGVtSWQ9TkU1NjA1OCZUcmFuc21pc3Npb25fSWQ9MjAyNTA0MDIxNDMyUFJfTkVXU19VU1BSX19fX19ORTU2MDU4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNDAyJk5ld3NJdGVtSWQ9TkU1NjA1OCZUcmFuc21pc3Npb25fSWQ9MjAyNTA0MDIxNDMyUFJfTkVXU19VU1BSX19fX19ORTU2MDU4"/></p>

西门子公司

西门子(ADR)

<p>Dotmatics 已与西门子公司签署了最终协议，以 51 亿美元的价格被收购。此次收购旨在通过将 Dotmatics 的研发软件与西门子的人工智能技术整合，增强其在生命科学领域的使命。该交易预计将加速创新周期并改善科学研究中的协作。该交易尚待监管机构的批准。作为科学软件的领导者，Dotmatics 在全球拥有超过 14,000 个客户，将受益于西门子丰富的资源和基础设施</p>

<ul>
<li>Siemens AG will acquire Dotmatics from global software investor Insight Partners for $5.1 billion</li>
<li>Acquisition accelerates Dotmatics' mission to connect scientific discovery to delivery, expanding global scale and reach</li>
<li>Unlocks new opportunities to combine Dotmatics' R&amp;D software with Siemens' AI-powered Digital Twin technologies</li>
<li>Represents a strong validation of Dotmatics' growth, innovation, and leadership in scientific software</li>
</ul>
<div class="lb-trans"><ul>
<li>西门子公司将以 51 亿美元收购全球软件投资者 Insight Partners 旗下的 Dotmatics</li>
<li>此次收购加速了 Dotmatics 将科学发现与交付相连接的使命，扩大了其全球规模和影响力</li>
<li>解锁了将 Dotmatics 的研发软件与西门子基于人工智能的数字双胞胎技术相结合的新机会</li>
<li>代表了对 Dotmatics 在科学软件领域的增长、创新和领导力的强有力验证</li>
</ul>
</div><p>, /PRNewswire/ -- Dotmatics®, a leading provider of scientific software that provides end-to-end solutions to connect science, data, and decision making for life sciences R&amp;D, today announced it has signed a definitive agreement to be acquired by Siemens AG for $5.1 billion.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Dotmatics®是一家领先的科学软件提供商，提供端到端解决方案以连接生命科学研发中的科学、数据和决策，今天宣布已签署最终协议，将以 51 亿美元被西门子公司收购。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Dotmatics has signed an agreement to be acquired by Siemens</p>
<div class="lb-trans"><p>Dotmatics 已签署协议将被西门子收购</p>
</div><p>&#34;Following an exciting journey with Insight Partners, where Dotmatics achieved remarkable growth and portfolio expansion, we are thrilled to announce our new chapter with Siemens,&#34; said Thomas Swalla, CEO of Dotmatics. &#34;Combining our next-generation scientific intelligence platform and industry-leading scientific applications together with Siemens' Digital Twin and AI capabilities, we'll drive a new wave of innovation in life sciences R&amp;D. Together, we'll accelerate innovation cycles for our customers and help scientists make breakthrough discoveries faster than ever before shaping the future of scientific innovation.&#34;</p>
<div class="lb-trans"><p>&#34;在与 Insight Partners 的激动人心的旅程之后，Dotmatics 实现了显著的增长和投资组合扩展，我们很高兴地宣布与西门子开启新的篇章，&#34; Dotmatics 首席执行官 Thomas Swalla 表示。&#34;将我们的下一代科学智能平台和行业领先的科学应用与西门子的数字双胞胎和人工智能能力结合在一起，我们将推动生命科学研发领域的新一波创新。我们将共同加速客户的创新周期，帮助科学家比以往更快地取得突破性发现，塑造科学创新的未来。&#34;</p>
</div><p>&#34;By acquiring Dotmatics, we're strategically strengthening our position in life sciences and creating a world-leading AI-powered PLM software portfolio as part of Siemens Xcelerator. Artificial Intelligence has emerged as a transformative force across various industries, and its application in life sciences is becoming increasingly important&#34;, said Roland Busch, President and CEO of Siemens AG. &#34;The Dotmatics acquisition is part of our ONE Tech Company growth program, enhancing our leading position in industrial software and helping our customers to innovate even faster.&#34;</p>
<div class="lb-trans"><p>&#34;通过收购 Dotmatics，我们正在战略性地增强在生命科学领域的地位，并作为西门子 Xcelerator 的一部分创建一个全球领先的基于人工智能的 PLM 软件组合。人工智能已成为各行业的变革性力量，其在生命科学中的应用变得越来越重要，&#34; 西门子公司总裁兼首席执行官 Roland Busch 表示。&#34;Dotmatics 的收购是我们 ONE Tech Company 增长计划的一部分，增强了我们在工业软件领域的领先地位，并帮助我们的客户更快地创新。&#34;</p>
</div><p>The acquisition will strengthen Siemens' and Dotmatics' ability to empower scientists through advanced software solutions that facilitate next-generation collaboration, contextualizes complex data, and accelerates research using AI. As part of Siemens, Dotmatics will benefit from expanded global resources, robust infrastructure, and a broader customer network, significantly advancing its mission to revolutionize scientific discovery for a healthier, cleaner, and safer world.</p>
<div class="lb-trans"><p>此次收购将增强西门子和 Dotmatics 通过先进软件解决方案赋能科学家的能力，这些解决方案促进下一代协作、上下文化复杂数据，并利用人工智能加速研究。作为西门子的一部分，Dotmatics 将受益于扩展的全球资源、强大的基础设施和更广泛的客户网络，显著推进其革命性科学发现的使命，以创造一个更健康、更清洁和更安全的世界。</p>
</div><p>Life sciences stands as one of the most rapidly evolving and innovation-rich sectors globally. The combination of Siemens' extensive manufacturing expertise, industrial simulation capabilities, and AI strengths, with Dotmatics' complementary scientific applications, will establish a first-of-its-kind end-to-end digital thread to seamlessly connect research data through to production in the life sciences industry.</p>
<div class="lb-trans"><p>生命科学是全球发展最快、创新最丰富的行业之一。西门子广泛的制造专业知识、工业仿真能力和人工智能优势与 Dotmatics 互补的科学应用相结合，将建立一个首创的端到端数字线程，顺畅连接生命科学行业的研究数据与生产。</p>
</div><p>&#34;When we first invested in what is now Dotmatics in 2017, we recognized the enormous potential of the platform being developed and the impact the company's technology would have on life sciences R&amp;D,&#34; said Jared Rosen, Managing Director at Insight Partners. &#34;It has been a privilege to collaborate closely with Thomas and the Dotmatics leadership team, actively supporting 14 strategic acquisitions and providing resources through our Onsite platform to fuel their impressive growth. The transition of Dotmatics from Insight Partners to Siemens represents a logical next step, empowering Dotmatics to further advance its mission of accelerating innovation within life sciences. This acquisition opens new avenues to seamlessly connect scientific discovery with manufacturing execution, enabling scientific R&amp;D organizations to rapidly and confidently transition breakthroughs from molecule to market.&#34;</p>
<div class="lb-trans"><p>&#34;当我们在 2017 年首次投资于现在的 Dotmatics 时，我们意识到该平台的巨大潜力以及公司技术对生命科学研发的影响，&#34; Insight Partners 的董事总经理 Jared Rosen 表示。&#34;与 Thomas 和 Dotmatics 领导团队密切合作，积极支持 14 项战略收购，并通过我们的 Onsite 平台提供资源以推动他们的显著增长，是一种特权。Dotmatics 从 Insight Partners 过渡到西门子代表了一个合乎逻辑的下一步，赋能 Dotmatics 进一步推进其加速生命科学创新的使命。这次收购开启了无缝连接科学发现与制造执行的新途径，使科学研发组织能够快速而自信地将突破性成果从分子转化为市场。&#34;</p>
</div><p><strong>Approvals &amp; Timing</strong> The transaction is expected to close following customary regulatory approvals and other closing conditions.</p>
<div class="lb-trans"><p><strong>批准与时间</strong> 该交易预计将在获得惯例监管批准和其他成交条件后完成。</p>
</div><p><strong>Advisors</strong> Evercore served as the exclusive financial advisor and Willkie Farr &amp; Gallagher LLP served as legal advisor to Dotmatics on the transaction.</p>
<div class="lb-trans"><p><strong>顾问</strong> Evercore 担任 Dotmatics 交易的独家财务顾问，Willkie Farr &amp; Gallagher LLP 担任法律顾问。</p>
</div><p><strong>About Dotmatics</strong> Dotmatics is a leader in R&amp;D scientific software connecting science, data, and decision-making. Its enterprise R&amp;D platform and applications, including GraphPad Prism, SnapGene and Geneious, drive efficiency and accelerate innovation. More than 2 million scientists and 14,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Dotmatics is a global team of more than 800 people dedicated to supporting its customers in over 180 countries. The company is headquartered in Boston, with 14 offices and R&amp;D teams located around the world. Learn more about Dotmatics at www.dotmatics.com.</p>
<div class="lb-trans"><p><strong>关于 Dotmatics</strong> Dotmatics 是连接科学、数据和决策的研发科学软件领导者。其企业研发平台和应用程序，包括 GraphPad Prism、SnapGene 和 Geneious，推动效率并加速创新。超过 200 万科学家和 14,000 个客户信任 Dotmatics，帮助他们创造一个更健康、更清洁、更安全的世界。Dotmatics 是一支由 800 多人组成的全球团队，致力于支持其在 180 多个国家的客户。公司总部位于波士顿，在全球设有 14 个办公室和研发团队。了解更多关于 Dotmatics 的信息，请访问 www.dotmatics.com。</p>
</div><p><strong>About Siemens</strong> Siemens AG (Berlin and Munich) is a leading technology company focused on industry, infrastructure, mobility, and healthcare. The company's purpose is to create technology to transform the everyday, for everyone. By combining the real and the digital worlds, Siemens empowers customers to accelerate their digital and sustainability transformations, making factories more efficient, cities more livable, and transportation more sustainable. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a leading global medical technology provider pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably. In fiscal 2024, which ended on September 30, 2024, the Siemens Group generated revenue of €75.9 billion and net income of €9.0 billion. As of September 30, 2024, the company employed around 312,000 people worldwide on the basis of continuing operations. Further information is available on the Internet at www.siemens.com.</p>
<div class="lb-trans"><p><strong>关于西门子</strong> 西门子公司（柏林和慕尼黑）是一家领先的技术公司，专注于工业、基础设施、移动和医疗保健。公司的宗旨是创造技术以改变日常生活，为每个人服务。通过将现实世界与数字世界相结合，西门子使客户能够加速其数字化和可持续性转型，使工厂更高效、城市更宜居、交通更可持续。西门子还拥有上市公司西门子医疗的控股权，西门子医疗是一家全球领先的医疗技术提供商，开创了医疗保健领域的突破性进展。为每个人。无处不在。可持续发展。在 2024 财年（截至 2024 年 9 月 30 日），西门子集团的收入为 759 亿欧元，净收入为 90 亿欧元。截至 2024 年 9 月 30 日，公司在持续运营的基础上全球雇佣约 312,000 名员工。有关更多信息，请访问 www.siemens.com。</p>
</div><p><strong>About Insight Partners</strong> Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of September 30, 2024, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 800 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has offices in London, Tel Aviv, and the Bay Area. Insight's mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.</p>
<div class="lb-trans"><p><strong>关于 Insight Partners</strong> Insight Partners 是一家全球软件投资公司，专注于与高增长的科技、软件和互联网初创企业及规模化公司合作，这些公司正在推动其行业的变革。截至 2024 年 9 月 30 日，该公司管理的监管资产超过 900 亿美元。Insight Partners 已在全球投资了 800 多家公司，并且已有超过 55 家投资组合公司成功上市。公司总部位于纽约市，在伦敦、特拉维夫和湾区设有办事处。Insight 的使命是寻找、资助并与具有远见的高管成功合作，为他们提供量身定制的、实用的软件专业知识，伴随他们的成长旅程，从首次投资到上市。有关 Insight 及其所有投资的更多信息，请访问 insightpartners.com 或在 X 上关注我们 @insightpartners。</p>
</div><p><strong>Forward Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements that do not relate solely to historical or current facts, such as statements regarding our expectations, intentions or strategies regarding the future. The forward-looking statements are based on management's beliefs, as well as assumptions made by, and information currently available to, Dotmatics. Because such statements are based on expectations as to future operating results they are not statements of fact. Actual results may differ materially from those projected and are subject to a number of known and unknown risks and uncertainties. The press release speaks only as of the date the statements are first published. Dotmatics undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.</p>
<div class="lb-trans"><p>本新闻稿包含前瞻性声明，这些声明不仅仅涉及历史或当前事实，例如关于我们对未来的期望、意图或战略的声明。这些前瞻性声明基于管理层的信念，以及 Dotmatics 所做的假设和当前可获得的信息。由于这些声明是基于对未来经营结果的期望，因此并非事实陈述。实际结果可能与预测结果有重大差异，并且受到已知和未知风险和不确定性的影响。新闻稿仅在声明首次发布的日期有效。Dotmatics 不承担更新任何前瞻性声明的义务，无论是由于新信息、未来事件还是其他原因。</p>
</div><p>SOURCE Dotmatics Inc</p>
<div class="lb-trans"><p>来源：Dotmatics Inc</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwNDAyJk5ld3NJdGVtSWQ9TkU1NjA1OCZUcmFuc21pc3Npb25fSWQ9MjAyNTA0MDIxNDMyUFJfTkVXU19VU1BSX19fX19ORTU2MDU4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NE56058&amp;Transmission_Id=202504021432PR_NEWS_USPR_____NE56058&amp;DateId=20250402"/></p>

Dotmatics 签署最终协议，将被西门子公司收购，推进生命科学领域的 AI 驱动创新新时代